Pliant Therapeutics PLRX
NASDAQ PLRX
$0.91 +0.01 (+1.52%)
At close: Oct 20, 2026 · 4:00 PM EDT

Pliant Therapeutics (PLRX) EV to CFO (2020)

Updated

Pliant Therapeutics' (PLRX) EV to CFO came in at 31.91 for Q3 2020, up 531.4% from the prior quarter.

Analysis

Pliant Therapeutics (PLRX) EV to CFO (2020) Analysis & Trends

For the trailing twelve months through Sep 30, 2020, EV to CFO at Pliant Therapeutics was 50.34.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 Pliant Therapeutics 56.49 Mn -705.25 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 31.91
Jun 30, 2020 5.05
API Access

Pliant Therapeutics EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=PLRX&period=max&api_key=YOUR_API_KEY